New Frontiers in Interventional Cardiology-Reference-Cited by-同舟云学术

New Frontiers in Interventional Cardiology

Published:2001-11-20 Issue:21 Volume:104 Page:2620-2626
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Teirstein Paul S.¹,Kuntz Richard E.¹

Affiliation:

1. From the Division of Cardiovascular Diseases (P.S.T.), Scripps Clinic, La Jolla, Calif; and the Divisions of Clinical Biometrics and Cardiology (R.E.K.), Brigham and Women’s Hospital, Boston, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/hc4601.099465

Reference46 articles.

1. Hall EJ. DNA strand breaks and chromosomal aberrations.In: Hall EJ ed. Radiobiology for the Radiologist. Philadelphia Penn: J. B. Lippincott Company; 1994: 15–73.

2. The molecular and cellular biologic basis for the radiation treatment of benign proliferative diseases

3. Jani SK. Handbook of Dosimetry for Radiotherapy. Boca Raton Fla: CRC Press 1993.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contemporary Use of Intracoronary Brachytherapy for In-Stent Restenosis: A Review;Cardiovascular Revascularization Medicine;2023-06

2. Is Coronary Brachytherapy Staging a Comeback for the Treatment of In-Stent Restenosis?;Current Cardiology Reports;2021-10-01

3. Avaliação tardia (> 10 anos) da braquiterapia intracoronária com radiação beta para restenose difusa intrastent;Revista Portuguesa de Cardiologia;2014-10

4. Late results (>10 years) of intracoronary beta brachytherapy for diffuse in-stent restenosis;Revista Portuguesa de Cardiologia (English Edition);2014-10

5. Endovascular Brachytherapy to Prevent Restenosis After Percutaneous Coronary Intervention;Therapeutic Nuclear Medicine;2012